Sarah Elkourashy Presents Insights on Caplacizumab for TTP at ASH25
Sarah Elkourashy, Consultant in Clinical Hematology and BMT at Hamad Medical Corporation, Assistant professor of clinical medicine at Weill Cornell Medicine-Qatar, shared on LinkedIn:
”Happy to be part of ASH Conference 2025 – ASH2025
It was a pleasure reconnecting with former colleagues and engaging with peers from across the hematology community.
The meeting offered valuable insights into the latest advances in hematology and meaningful discussions on how to further enhance the care of patients with hematological disorders.
Thankful for the rich scientific exchange and collaborative environment.
Delighted to present our poster there Shehab Mohamed, Abdulrahman Al-Mashdali
Abstracts accepted:
1.Real-world descriptive analysis of the use of bispecific t cell engagers (BiTEs) in the treatment of hematological malignancies in Qatar: A state-wide retrospective study cohort
Read the full article in Blood.
Authors: Rawan Dawoud, Farah Jibril, Maria Benkhadra, Sahar Nasser, Amaal Gulied, Anas Hamad, Honar Charif, Mohamed Yassin, Ruba Yasin Taha, Safaa Alazawi, Hesham Elsabah, Deena Mudawi, Sarah Elkourashy, Shereen Elazzazy
2.Caplacizumab as a pre-emptive therapy in thrombotic thrombocytopenic purpura: A proactive strategy to reduce morbidity
Read the full article in Blood.
Authors: Maria Benkhadra, Abdulrahman Al-Mashdali, Sarah Elkourashy, Anas Hamad, Shehab Mohamed, Halima El Omri, Honar Cherif
3.Caplacizumab for pediatric immune thrombotic thrombocytopenic purpura: A scoping review of current evidence
Read the full article in Blood.
Authors: Abdulrahman Al-Mashdali, Samah M Salihb, Priyadarshini Vatsyayanc, Deena Mudawi, Sarah Elkourashy, Dina Soliman, Honar Charif, Shehab Mohamed
All from ASH25 featured in Hemostasis Today.
-
Sep 30, 2026, 15:58Bernhard Merget: New Frontiers in Thrombosis and Stroke Research
-
Sep 30, 2026, 15:39Ifeanyichukwu Ifechidere: The Molecular Orchestra of Primary Hemostasis
-
Sep 30, 2026, 15:28Reassessing the Benefit–Risk Balance of Extended Anticoagulation in Cancer Patients – ESC Working Group on Cardiovascular Pharmacotherapy
-
Sep 30, 2026, 15:07Chiranjeev Sharma: Targeting Factor XIa with the Synthetic Inhibitor SB-01
-
Sep 30, 2026, 14:41Bruna Gigante: Balancing Thrombosis and Bleeding in Cardiovascular Care
-
Sep 30, 2026, 14:13Ashok Choudhury: Portal Vein Thrombosis and Outcomes in Cirrhosis
-
Sep 30, 2026, 13:57Leslye Conde Bazán: When Conventional Imaging Is Not Enough – The Role of IVUS
-
Sep 30, 2026, 13:41Huda Salah Eldin: The Challenge of Balancing Antithrombotic Therapy After PCI
-
Sep 30, 2026, 13:29Abdus Salam: What Can CT Venography Reveal About the Veins?